BridgeBio Pharma, Inc.
Develops transformative medicines for genetic diseases and genetically driven cancers.
BBIO | NDAQ
Overview
Corporate Details
- ISIN(s):
- US10806X1028
- LEI:
- Country:
- United States of America
- Address:
- 3160 PORTER DR., 94304 PALO ALTO
- Website:
- https://bridgebio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BridgeBio Pharma, Inc. is a commercial-stage biopharmaceutical company that discovers, creates, tests, and delivers transformative medicines for patients with genetic diseases and cancers with clear genetic drivers. The company's mission is to bridge the gap between advancements in genetic science and patients with unmet needs. It utilizes a development platform that integrates finance and science to accelerate the process of turning scientific discoveries into patient solutions as quickly and safely as possible.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BridgeBio Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BridgeBio Pharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BridgeBio Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
